Participation in phase III ADEBAR: evaluating the role of adjuvant docetaxel in high-risk breast cancer patients improves treatment strategies and individual patient care in recruiting centers
F von Bismarck, W Janni, B Rack, W Thieleke, B Strobl, D Steinfeld, D Augustin, H Sommer, M Kiechle, N HarbeckVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)90655-6
File:
PDF, 160 KB
english, 2004